Plain-English translation of NCT06326424 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing whether a wearable wrist biosensor—a special watch that tracks movement and body signals—can help doctors quickly identify when older adults with dementia develop sudden confusion (called delirium) in the emergency department. Researchers will collect data from the watch and compare it with standard confusion assessments to see if the technology works accurately.
Sudden confusion is common in older adults with dementia who go to the hospital, but it can be hard for doctors to spot quickly. This trial aims to develop a better, faster way to detect this dangerous condition using technology so patients get help sooner.
You likely qualify if…
You likely don't qualify if…
You will wear a small wrist biosensor watch (like a fitness tracker) for up to 48 hours while in the emergency department or hospital. During this time, doctors will perform standard confusion assessments at enrollment and at 24 and 48 hours (or when you're discharged). You and your caregiver will also answer a few questions about comfort with wearing the watch, either before you leave the hospital or by phone later at home.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States
Enrollment target
~60 participants
Started
April 2024
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
65 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lauren Southerland, MD MPH
Ohio State University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.